FDA Investigator Stephen J Kilker

Stephen J Kilker has conducted inspections on 223 sites in 5 countries as of 06 Mar 2012. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
223
Last Inspection Date:
06 Mar 2012
Investigator Role:
FDA Investigator
Redica ID:
100001894
Countries of Inspections:
United States of America, China, Canada, Malawi, Thailand
FDA Investigators that have inspected at least one site in common with Stephen J Kilker:
Aaron J Fox, Allison E Sincek, Amy L Mccarthy, Andrew J Barrowcliff, Andrew J Lang, Andrew R Wasko, Andria L Kuhlman, Annemarie H Cochran, Annemarie Kleiza, Arie R Dyk, Benjamin J Dastoli, Benjamin P Stewart, Billy Moore, SIT, Brittany M Kershaw, Bryan J Love, Carol Rivera Lopez, PhD, Charles M Edwards, Christopher D Snyder, Christopher T Middendorf, Clinton D Priestley, Craig T Rybus, Cynthia L Rakestraw, D'arbra R Blankenship, Daniel J Mechenbier, Darla J Christopher, Darren S Morgan, Deborah M Trout, Dell S Moller, Denise D Dion, Diane Hall, Diane M Fresch, Dr. Abhijit Raha, PhD, Dr. Mark J Seaton, PhD, Dr. Sriram Subramaniam, PhD, Dr. Zhou Chen (nmi), MD PhD, Edward R Kay, Elizabeth Ll Edwards, Erica L Nicoll, Erika V Butler, Felix Maldonado, Frederick M Lochner, Gayle S Lawson, Geoffrey K Kilili, George J Flynn, Gilbert J Heidenblut, Hugh M Mcclure, II, James R Evans, Janet L Bowen, Jazmine N Still, Jennifer L Gustavus, Jennifer L Sheehan, Jennifer M Heitz, Jose R Hernandez, Judy Ellen Ciaraldi, Julie D Bringger, Karen M Cooper, Karen M Kondas, Katherine Szestypalow, Kathleen D Culver, Kathryn J Mccarty, Kathryn Suttling, Larry K Austin, Laureen M Geniusz, Lindsey M Schwierjohann, Lisa M Marko, LTJG Bradley E Benasutti, Marcia A Worley, Marianne Allen, Marijo B Kambere, PhD, Mark E Parmon, Mary E Storch, Matthew B Casale, Matthew H Pitts, Matthew J Gretkierewicz, Michael E Clark, Michael J Schibi, Michael P Sheehan, Mishelle L Harriger, Nancy L Neiger, Neal L Adams, Nicholas L Paulin, Nisha C Patel, Paul A Bonneau, Paul E Stein, Paula A Trost, Payne, Peter C Chow, Peter E Baker, Phillip M Pontikos, Pifer, Ralph A Erickson, Regina I Stoltzfus, Regina T Brown, Richard W Berning, Robert Jennings, Rosanna M Goodrich, Rose Ashley, Roy C Stephens, Said H Muse, Shankar L Saha, Sneha S Patel, Stephanie Mangigian, MS/OSH, RN, Stephen J Rabe, Tamara M Kays, Thomas J Arista, Thomas W Nojek, Thunder N Dunkijacobs, Travis R Hunt, Travis V Hull, Uduak M Inokon, Walden H Lee, Yiyue Zhang (nmi), PhD, Yvette Mlacour Davis

Stephen J Kilker's Documents

Publish Date Document Type Title
September, 2004 FDA 483 REESE PHARMACEUTICAL CO. - Form 483, 2004-09-29
December, 2008 FDA 483 Cleveland Clinic Mercy Hospital IRB - Form 483, 2008-12-15
June, 2007 FDA 483 Ben Venue Laboratories Inc. - Form 483, 2007-06-15
April, 2000 FDA 483 Frontage Laboratories, Inc. - Form 483, 2000-04-12
January, 2000 EIR Michael J Manos PhD - EIR, 2000-01-24
June, 2009 FDA 483 Response Oliver C Eshenaur DO - Form 483R, 2009-06-22
November, 2011 FDA 483 St. Vincent Charity Medical Center - Form 483, 2011-11-15
October, 2009 FDA 483 Precision Herbs LLC - Form 483, 2009-10-14
September, 2007 FDA 483 Response Frederick C Whittier J MD - Form 483R, 2007-10-08
June, 2003 EIR Charles River Laboratories Ashland, LLC - EIR, 2003-06-20
September, 2007 FDA 483 Frederick C Whittier J MD - Form 483, 2007-09-12
December, 2002 FDA 483 Emad Dean Nukta MD - Form 483, 2002-12-12
June, 2009 EIR Oliver C Eshenaur DO - EIR, 2009-06-17
March, 2002 EIR Musculoskeletal Transplant Foundation - EIR, 2002-03-08
March, 2005 FDA 483 Robert W Hostoffer - Form 483, 2005-03-02
September, 2003 FDA 483 Bonne Bell LLC - Form 483, 2003-09-10
June, 2009 FDA 483 Oliver C Eshenaur DO - Form 483, 2009-06-17
December, 2000 FDA 483 Julian L Peskin MD - Form 483, 2000-12-08
October, 2009 FDA 483 Charles River Laboratories Ashland, LLC - Form 483, 2009-10-30
March, 2000 EIR Charles River Laboratories Ashland, LLC - EIR, 2000-03-03
December, 2009 FDA 483 Nashat Y Gabrail MD - Form 483, 2009-12-17
July, 2007 EIR Tracy Hull MD - EIR, 2007-07-18
April, 2000 FDA 483 Response Frontage Laboratories, Inc. - Form 483R, 2000-04-19
October, 2009 EIR Charles River Laboratories Ashland, LLC - EIR, 2009-10-30
March, 2006 FDA 483 Nashat Y Gabrail MD - Form 483, 2006-03-17
April, 2001 FDA 483 Charles River Laboratories Ashland, LLC - Form 483, 2001-04-20
August, 2000 FDA 483 Response Gliatech Inc - Form 483R, 2000-09-14
May, 2011 EIR North American Science Associates, LLC - EIR, 2011-05-26
November, 2001 FDA 483 Response Suyu Shu PhD - Form 483R, 2002-04-04
August, 2000 FDA 483 Gliatech Inc - Form 483, 2000-08-23
July, 2002 FDA 483 Aultman Hospital - Form 483, 2002-07-01
May, 2010 EIR Mira Baron MD - EIR, 2010-05-11
June, 2001 EIR Ben Venue Laboratories Inc. - EIR, 2001-06-04
January, 2003 EIR Gerald M Burma MD - EIR, 2003-01-17
November, 2001 EIR Suyu Shu PhD - EIR, 2001-11-13
May, 2010 EIR Mira Baron MD - EIR, 2010-05-27
November, 2001 FDA 483 Suyu Shu PhD - Form 483, 2001-11-13
August, 2010 EIR Shishuka Malhotra MD - EIR, 2010-08-12
April, 2000 EIR Frontage Laboratories, Inc. - EIR, 2000-04-12
March, 2011 FDA 483 Mira Baron MD - Form 483, 2011-03-02
April, 2001 EIR Charles River Laboratories Ashland, LLC - EIR, 2001-04-20
March, 2002 FDA 483 Musculoskeletal Transplant Foundation - Form 483, 2002-03-08
July, 2008 FDA 483 Ben Venue Laboratories Inc. - Form 483, 2008-07-17
October, 2001 FDA 483 Ben Venue Laboratories Inc. - Form 483, 2001-10-26
October, 2001 EIR Ben Venue Laboratories Inc. - EIR, 2001-10-26
July, 2007 FDA 483 Tracy Hull MD - Form 483, 2007-07-18
July, 2009 FDA 483 Zhejiang Hisun Pharmaceutical Co., Ltd. - Form 483, 2009-07-23
January, 2003 FDA 483 Gerald M Burma MD - Form 483, 2003-01-17
September, 2008 FDA 483 Frontage Laboratories, Inc. - Form 483, 2008-09-30
December, 2003 FDA 483 Case Western Reserve University - Form 483, 2003-12-09
September, 2007 EIR Frederick C Whittier J MD - EIR, 2007-09-12
November, 2008 FDA 483 Cleveland Clinic - Form 483, 2008-11-03
May, 2009 FDA 483 Ben Venue Laboratories Inc. - Form 483, 2009-05-13
September, 2010 FDA 483 Michael M. Lederman MD - Form 483, 2010-09-20
December, 2000 EIR Julian L Peskin MD - EIR, 2000-12-08

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more